Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
- 31 May 2010
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 123 (5), 468.e9-468.e17
- https://doi.org/10.1016/j.amjmed.2009.11.019
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Weight Change in Diabetes and Glycemic and Blood Pressure ControlDiabetes Care, 2008
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 DiabetesDiabetes Care, 2007
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 DiabetesDiabetes Care, 2004
- Influence of Weight Reduction on Blood PressureHypertension, 2003
- Treatment of Hypertension in Adults With DiabetesDiabetes Care, 2003
- Diet and Exercise Among Adults With Type 2 DiabetesDiabetes Care, 2002
- Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patientsDiabetes Care, 1996
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding SitesEuropean Journal of Neuroscience, 1995